Tenecteplase in Stroke Patients Between 4 5 and 24 Hours
Research payments
$6,851,168
Through program year 2025, $6,851,168 in research payments was reported against Tenecteplase in Stroke Patients Between 4 5 and 24 Hours, across 1,345 payments.
- Paid by (largest first)
- Genentech, Inc.; F. Hoffmann-La Roche AG
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $16,561 | 14 |
| 2024 | Research | $167,698 | 83 |
| 2023 | Research | $873,061 | 342 |
| 2022 | Research | $1,720,332 | 252 |
| 2021 | Research | $1,352,964 | 262 |
| 2020 | Research | $1,767,863 | 292 |
| 2019 | Research | $952,689 | 100 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Christopher Streib Minneapolis, MN Named on 47 payments
- Minjee Kim Chicago, IL Named on 40 payments
- Michael Froehler Nashville, TN Named on 30 payments
- Charles Kircher Cincinnati, OH Named on 30 payments
- Mouhammad Jumaa Toledo, OH Named on 21 payments
- Nadeem Khan Grand Rapids, MI Named on 19 payments
- Scott Kasner Camden, NJ Named on 18 payments
- Jin-Moo Lee Saint Louis, MO Named on 17 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.